Treatment of pyoderma gangrenosum

被引：2
|
作者：
Anstey, AV
机构：
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 1997年 / 36卷 / 05期
关键词：
THIOPURINE METHYLTRANSFERASE ACTIVITY; GENETIC-POLYMORPHISM; AZATHIOPRINE; PHARMACOGENETICS;
D O I：
10.1016/S0190-9622(97)80356-8
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：802 / 802
页数：1
相关论文
共 50 条
  • [31] Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease
    Hindorf, U.
    Johansson, M.
    Eriksson, A.
    Kvifors, E.
    Almer, S. H. C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (06) : 654 - 661
  • [32] Azathioprine treatment in inflammatory bowel disease patients: type and time of onset of side effects
    Avallone, E. V.
    Pica, R.
    Cassieri, C.
    Zippi, M.
    Paoluzi, P.
    Vernia, P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (02) : 165 - 170
  • [33] The Role of Pharmacogenetics in the Therapeutic Response to Thiopurines in the Treatment of Inflammatory Bowel Disease: A Systematic Review
    Ribeiro, Aline C.
    Gerheim, Pamela S. A. S.
    Chebli, Julio Maria Fonseca
    Nascimento, Jorge Willian L.
    Pinto, Priscila de Faria
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (21)
  • [34] An audit of thiopurine methyltransferase genotyping and phenotyping before intended azathioprine treatment for dermatological conditions
    Vestergaard, T.
    Bygum, A.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2010, 35 (02) : 140 - 144
  • [35] Pharmacogenomics in cancer treatment defining genetic bases for inter-individual differences in responses to chemotherapy
    Ansari, Marc
    Krajinovic, Maja
    CURRENT OPINION IN PEDIATRICS, 2007, 19 (01) : 15 - 22
  • [36] Prevalence of hepatotoxicity and myelosuppression with alternate day use of azathioprine and glucocorticoids for treatment of dermatological conditions in dogs
    Eberhardy, Aurrielle C.
    Heinrich, Nicole A.
    McFadden, Rendina A.
    Reiter, Lisa, V
    VETERINARY DERMATOLOGY, 2022, 33 (06) : 503 - +
  • [37] A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study
    Newman, William G.
    Payne, Katherine
    Tricker, Karen
    Roberts, Stephen A.
    Fargher, Emily
    Pushpakom, Sudeep
    Alder, Jane E.
    Sidgwick, Gary P.
    Payne, Debbie
    Elliott, Rachel A.
    Heise, Marco
    Elles, Robert
    Ramsden, Simon C.
    Andrews, Julie
    Houston, J. Brian
    Qasim, Faeiza
    Shaffer, Jon
    Griffiths, Christopher E. M.
    Ray, David W.
    Bruce, Ian
    Ollier, William E. R.
    PHARMACOGENOMICS, 2011, 12 (06) : 815 - 826
  • [38] Enrichment of Genetic Variants in the Glucocorticoid Receptor Signalling Pathway in Autoimmune Hepatitis with Failure of Standard Treatment
    Eriksen, Peter Lykke
    Kreutzfeldt, Martin
    Gronbaek, Henning
    Thorsen, Kasper
    Vang, Soren
    Jessen, Niels
    Vilstrup, Hendrik
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2017, 121 (03) : 189 - 194
  • [39] Lack of association between the APOE genotype and the response to statin treatment in patients with acute ischemic episodes
    Oliveira Sousa, Marinez
    Corbella, Emilio
    Alia, Pedro
    Camara, Jordi
    Jose Castro, Maria
    Pinto, Xavier
    Angel Navarro, Miguel
    MEDICINA CLINICA, 2008, 130 (11): : 401 - 404
  • [40] Use of Pharmacogenetics, Enzymatic Phenotyping, and Metabolite Monitoring to Guide Treatment with Azathioprine in Patients with Systemic Lupus Erythematosus
    Askanase, Anca D.
    Wallace, Daniel J.
    Weisman, Michael H.
    Tseng, Chung-E
    Bernstein, Lana
    Belmont, H. Michael
    Seidman, Ernest
    Ishimori, Mariko
    Izmirly, Peter M.
    Buyon, Jill P.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (01) : 89 - 95
12345